OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review paper Cathelicidin impact on inflammatory cells
Justyna Agier, Magdalena Efenberger-Szmechtyk, Ewa Brzezińska‐Błaszczyk
Central European Journal of Immunology (2015) Vol. 2, pp. 225-235
Open Access | Times Cited: 172

Showing 26-50 of 172 citing articles:

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
Zohaib Khurshid, Mustafa Naseem, Faris Yahya I. Asiri, et al.
Biomolecules (2017) Vol. 7, Iss. 4, pp. 80-80
Open Access | Times Cited: 54

Hoodwinking the Big-Eater to Prosper: The <b><i>Salmonella</i></b>-Macrophage Paradigm
Mayuri Gogoi, Meghanashree M. Shreenivas, Dipshikha Chakravortty
Journal of Innate Immunity (2018) Vol. 11, Iss. 3, pp. 289-299
Open Access | Times Cited: 52

Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections
Aslaa Ahmed, Gavriella Siman-Tov, Forrest Keck, et al.
Antiviral Research (2019) Vol. 164, pp. 61-69
Open Access | Times Cited: 52

The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation
Maryam Salamah, Divyashree Ravishankar, Xenia Kodji, et al.
Blood Advances (2018) Vol. 2, Iss. 21, pp. 2973-2985
Open Access | Times Cited: 50

Snake Venom Cathelicidins as Natural Antimicrobial Peptides
Elizângela de Barros, Regina Meneses Gonçalves, Marlon H. Cardoso, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 50

Personalized pharmacological therapy for ARDS: a light at the end of the tunnel
Pedro Leme Silva, Paolo Pelosi, Patrícia R. M. Rocco
Expert Opinion on Investigational Drugs (2019) Vol. 29, Iss. 1, pp. 49-61
Open Access | Times Cited: 45

Novel therapeutic interventions towards improved management of septic arthritis
Jian Wang, Liucai Wang
BMC Musculoskeletal Disorders (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 38

COVID-19 and nutritional deficiency: a review of existing knowledge
Meghana Muthuvattur Pallath, Ashok Kumar Ahirwar, S. C. Tripathi, et al.
Hormone Molecular Biology and Clinical Investigation (2021) Vol. 42, Iss. 1, pp. 77-85
Closed Access | Times Cited: 36

An in silico scientific basis for LL‐37 as a therapeutic for Covid‐19
Kiran Bharat Lokhande, Tanushree Banerjee, K. Venkateswara Swamy, et al.
Proteins Structure Function and Bioinformatics (2021) Vol. 90, Iss. 5, pp. 1029-1043
Open Access | Times Cited: 33

Therapeutic Potential of Antimicrobial Peptides for Wound Healing
Sepideh Nasseri, Mohammadreza Sharifi
International Journal of Peptide Research and Therapeutics (2022) Vol. 28, Iss. 1
Closed Access | Times Cited: 24

The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities
Lixian Mu, Lei Zhou, Juanjuan Yang, et al.
Amino Acids (2017) Vol. 49, Iss. 9, pp. 1571-1585
Open Access | Times Cited: 46

Myeloid Populations in Systemic Autoimmune Diseases
María Morell, Nieves Varela, Concepción Marañón
Clinical Reviews in Allergy & Immunology (2017) Vol. 53, Iss. 2, pp. 198-218
Closed Access | Times Cited: 42

Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells
Justyna Agier, Ewa Brzezińska‐Błaszczyk, Paulina Żelechowska, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-18
Open Access | Times Cited: 42

Galleria mellonella: A Novel Invertebrate Model to Distinguish Intestinal Symbionts From Pathobionts
Anna Lange, Andrea Schäfer, Annika Bender, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 42

Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
Christie Mitri, Zhengzhong Xu, Pauline Bardin, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 38

Roles of airway and intestinal epithelia in responding to pathogens and maintaining tissue homeostasis
Marcela Ambrogi, Chad M. Vezina
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4

Immunomodulatory properties of chicken cathelicidin-2 investigated on an ileal explant culture
Gábor Mátis, Patrik Tráj, Viktória Hanyecz, et al.
Veterinary Research Communications (2024) Vol. 48, Iss. 4, pp. 2527-2535
Open Access | Times Cited: 4

Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions
Iman Owliaee, Mehran Khaledian, Ali Shojaeian, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access

Vitamin D deficiency in overweight patients: current strategies and practical aspects
Т. Л. Каронова, В. В. Салухов, Larisa Dzeranova, et al.
Problems of Endocrinology (2025) Vol. 71, Iss. 1, pp. 92-98
Closed Access

Antimicrobial potential of biopolymers against foodborne pathogens: An updated review
Md. Anowar Khasru Parvez, Fatema Tuz Jubyda, Joyoshrie Karmakar, et al.
Microbial Pathogenesis (2025) Vol. 204, pp. 107583-107583
Closed Access

Heat-inactivated Mycobacterium bovis and P22PI protein immunocomplex: two candidates for use as immunostimulants of innate immune response
Irene Agulló‐Ros, Mercedes Burucúa, F Valenzuela, et al.
Veterinary Microbiology (2025), pp. 110527-110527
Open Access

LL37 promotes angiogenesis: a potential therapeutic strategy for lower limb ischemic diseases
Yingying Yang, Gang Wu, Yini Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Scroll to top